XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities:    
Net income $ 360.8 $ 369.4
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and loss on disposal of property, plant, and equipment 87.7 77.7
Amortization of intangible assets 5.0 6.1
Gain on sale of business 0.0 (3.8)
Loss on investments, accretion of discounts, and amortization of premiums on investments, net 4.9 26.0
Deferred income taxes 9.3 (14.4)
Share-based compensation expense 139.8 120.8
Amortization of contract acquisition assets 7.4 6.6
Changes in operating assets and liabilities, net of effects of acquisitions:    
Accounts receivable 16.9 (123.4)
Inventory (127.1) (120.1)
Prepaids and other assets (27.3) (21.7)
Accounts payable 16.9 (1.9)
Accrued compensation and employee benefits (140.6) (130.3)
Deferred revenue 24.2 11.4
Other liabilities (6.5) 20.6
Net cash provided by operating activities 371.4 223.0
Investing activities:    
Purchase of investments (3.5) (1,187.3)
Proceeds from sales of investments 26.3 0.0
Proceeds from maturities of investments 744.4 1,067.7
Purchase of property, plant, and equipment (194.1) (93.6)
Acquisition of businesses, net of cash, and intellectual property and other investing activities 0.0 (1.5)
Net cash provided by (used in) investing activities 573.1 (214.7)
Financing activities:    
Proceeds from issuance of common stock relating to employee stock plans 100.2 80.0
Taxes paid related to net share settlement of equity awards (129.7) (172.2)
Repurchase of common stock (350.0) (106.5)
Payment of deferred purchase consideration (1.7) (1.2)
Net cash used in financing activities (381.2) (199.9)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 1.8 3.8
Net increase (decrease) in cash, cash equivalents, and restricted cash 565.1 (187.8)
Cash, cash equivalents, and restricted cash, beginning of period 1,600.7 1,306.0
Cash, cash equivalents, and restricted cash, end of period $ 2,165.8 $ 1,118.2